FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma Pharmaceuticals USA Inc.'s supplemental application for Mycophenolate mofetil, a generic immunosuppressant used to prevent organ transplant r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Kidney Transplant
• Liver Transplant

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)